Skip Navigation

European Heart Journal 1993 14(1):34-39;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by DERCHI, G.
Right arrow Articles by ROULEAU, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DERCHI, G.
Right arrow Articles by ROULEAU, J. L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The European Society of Cardiology

Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure

G. DERCHI, J. DUPUIS, J. DE CHAMPLAIN and J. L. ROULEAU

Centre de recherche, Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montréal and Service de Cardiologie, Université de Sherbrooke Sherbrooke (Québec) Canada

Received 21 October 1991; revised 11 May 1992; .

Correspondence: Giorgio Derchi, Divisione di Cardiologia, E.O. Ospedali Galhera, Via Volta 8, 16128 Genova, Italia

Abstract

Neuropeptide Y (NPY) is thought to be co-released with catecholamines in response to major cardiovascular stresses, but its relation to the release of catecholamines in response to minor stresses has been less well described. We therefore studied the response of plasma NPY-like immunoreactivity (NPY-Li) levels to standing (10 min) in eight normal subjects and 11 patients with congestive heart failure, and to short-term (6 h) vasodilator therapy in 13 patients with congestive heart failure. In both normal and heart failure patients, NPY-Li decreased (296±73 to 233±63 pg.ml–1 and 652±36 to 516±25 pg.ml–1 (P <0.01) respectively) in response to standing, whereas catecholamines increased in both groups (norepi-nephrine 203±73 to 507± 165 pg.ml–1 and 493±197 to 813±336 pg. ml–1 (P<0001) respectively and epinephrine 23±12 to 38±12 pg.ml and 46±19 to 62±28 pg.ml–1 (P <0.001 respectively). Both basal circulating NPY-Li and catecholamine levels were markedly increased in congestive heart failure patients, but catecholamines and NPY-Li did not correlate with each other. After 6 h of nitroglycerin infusion, mean arterial pressure was decreased, but circulating neurohumoral levels remained unchanged and NPY-Li levels decreased (653±37 to 517±26 pg.ml–1 P<0.01). It is concluded that basal circulating NPY-Li and catecholamine levels are increased in congestive heart failure and that this neurohormone could play a concomittant role in the increase in peripheral resistance in these patients. However, changes in circulating NPY-Li levels correlate poorly with changes in circulating catecholamines in response to minor cardiovascular stress in normal and heart failure patients. These results suggest a differential release of these two sympathetic neurotransmitters.

Key Words: Neuropeptide Y • catecholamines • congestive heart failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Degousee, D. Angoulvant, S. Fazel, E. Stefanski, S. Saha, K. Iliescu, T. F. Lindsay, J. E. Fish, P. A. Marsden, R.-K. Li, et al.
c-Jun N-terminal Kinase-mediated Stabilization of Microsomal Prostaglandin E2 Synthase-1 mRNA Regulates Delayed Microsomal Prostaglandin E2 Synthase-1 Expression and Prostaglandin E2 Biosynthesis by Cardiomyocytes
J. Biol. Chem., June 16, 2006; 281(24): 16443 - 16452.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Di Napoli, A A Taccardi, and A Barsotti
Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy
Heart, February 1, 2005; 91(2): 161 - 165.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
D L Sudakin
Occupational exposure to aluminium phosphide and phosphine gas? A suspected case report and review of the literature
Human and Experimental Toxicology, January 1, 2005; 24(1): 27 - 33.
[Abstract] [PDF]


Home page
Exp. Biol. Med.Home page
S. C. Park, Y. Liu-Stratton, L. C. Medeiros, S. A. Mccune, and M. J. Radin
Effect of Male Sex and Obesity on Platelet Arachidonic Acid in Spontaneous Hypertensive Heart Failure Rats
Experimental Biology and Medicine, July 1, 2004; 229(7): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G.-J. Wang, A. Y.-C. Shum, Y.-L. Lin, J.-F. Liao, X.-C. Wu, J. Ren, and C.-F. Chen
Calcium Channel Blockade in Vascular Smooth Muscle Cells: Major Hypotensive Mechanism of S-Petasin, a Hypotensive Sesquiterpene from Petasites formosanus
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 240 - 246.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
A. Birand, G. Z. Kudaiberdieva, T. A. Batyraliev, F. Akgul, and A. Usal
Effects of Trimetazidine on Heart Rate Variability and Left Ventricular Systolic Performance in Patients with Coronary Artery Disease After Percutaneous Transluminal Angioplasty
Angiology, May 1, 1997; 48(5): 413 - 422.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Graves, K. E. Bornfeldt, J. S. Sidhu, G. M. Argast, E. W. Raines, R. Ross, C. C. Leslie, and E. G. Krebs
Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells
J. Biol. Chem., January 5, 1996; 271(1): 505 - 511.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.